Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent

Cell Biology and Toxicology

Volumn 30, Issue 1, 2014, Pages 55-66

  Ormsby, Rebecca J ^a   Lawrence, Mark D ^a   Blyth, Benjamin J ^a   Bexis, Katrina ^a   Bezak, Eva ^b   Murley, Jeffrey S ^c   Grdina, David J ^c   Sykes, Pamela J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amifostine; Apoptosis; Free radical scavengers; Low dose X radiation; Radioprotectors; X radiation

Indexed keywords

AMIFOSTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROTECTION; CONTROLLED STUDY; FEMALE; LOW ENERGY RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RADIATION RESPONSE; SPLEEN CELL; WHOLE BODY RADIATION; X RAY;

MUS;

AMIFOSTINE; ANIMALS; APOPTOSIS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; MALE; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; SPLEEN;

EID: 84895449795     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-014-9268-3     Document Type: Article

References (82)

1. Acosta JC, Richard C, Delgado MD, Horita M, Rizzo MG, Fernandez-Luna JL, et al. Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells. Mol Cancer Ther. 2003;2:893-900.
2. Amundson SA, Lee RA, Koch-Paiz CA, Bittner ML, Meltzer P, Trent JM, et al. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res. 2003;1:445-52. (Pubitemid 36459255)
3. Anelli L, Albano F, Zagaria A, Liso A, Cuneo A, Mancini M, et al. Pericentric chromosome 8 inversion associated with the 5′ RUNX1/3′CBFA2T1 gene in acute myeloid leukemia cases. Ann Hematol. 2005;84:245-9. (Pubitemid 40425071)
4. Asou N, Sanada I, Tanaka K, Hidaka M, Suzushima H, Matsuzaki H, et al. Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;61:197-200.
5. Belkacémi Y, Rat P, Piel G, Christen M-O, Touboul E, Warnet J-M. Lens epithelial cell protection by aminothiol WR-1065 and anetholedithiolethione from ionizing radiation. Int J Cancer. 2001;96:15-26.
6. Bisht KS, Prabhu S, Devi PU. Modification of radiation induced damage in mouse intestine by WR-2721. Indian J Exp Biol. 2000;38:669-74.
7. Blyth BJ, Azzam EI, Howell RW, Ormsby RJ, Staudacher AH, Sykes PJ. An adoptive transfer method to detect low-dose radiation-induced bystander effects in vivo. Radiat Res. 2010;173:125-37.
8. Boreham DR, Dolling JA, Maves SR, Siwarungsun N, Mitchel RE. Dose-rate effects for apoptosis and micronucleus formation in gamma-irradiated human lymphocytes. Radiat Res. 2000;153:579-86. (Pubitemid 30252606)
9. Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339-45.
10. Broerse JJ, Hennen LA, Solleveld HA. Actuarial analysis of the hazard for mammary carcinogenesis in different rat strains after X- and neutron irradiation. Leuk Res. 1986;10:749-54. (Pubitemid 16058583)
11. Broerse JJ, Hennen LA, Klapwijk WM, Solleveld HA. Mammary carcinogenesis in different rat strains after irradiation and hormone administration. Int J Radiat Biol Relat Stud Phys Chem Med. 1987;51:1091-100. (Pubitemid 17091062)
12. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis. 1990;11:847-53. (Pubitemid 20150256)
13. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.
14. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 1993;362:849-52. (Pubitemid 23132162)
15. Coggle JE. Lung tumour induction in mice after X-rays and neutrons. Int J Radiat Biol Relat Stud Phys Chem Med. 1988;53:585-97.
16. Damron TA, Mathur S, Horton JA, Strauss J, Margulies B, Grant W, et al. Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-beta, and FGF-2 expression following growth plate irradiation with or without radioprotectant. J Histochem Cytochem. 2004;52:157-67. (Pubitemid 38146574)
17. Day TK, Zeng G, Hooker AM, Bhat M, Scott BR, Turner DR, et al. Adaptive response for chromosomal inversions in pKZ1 mouse prostate induced by lowdoses of X radiation delivered after a high dose. Radiat Res. 2007a;167:682-92. (Pubitemid 351292948)
18. Day TK, Zeng G, Hooker AM, Bhat M, Turner DR, Sykes PJ. Extremely low doses of X-radiation can induce adaptive responses in mouse prostate. Dose-response. 2007b;5:315-22.
19. Denny CT, Hollis GF, Hecht F, Morgan R, Link MP, Smith SD, et al. Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science. 1986;234:197-200. (Pubitemid 17186097)
20. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys. 1995;33:781-96.
21. Diedrich MJ, Warters RL, Grossman D. Amifostine aminothiols and protection of keratinocyte apoptosis and DNA damage. J Invest Dermatol. 2002;119:707-8.
22. Ding LH, Shingyoji M, Chen F, Hwang JJ, Burma S, Lee C, et al. Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high doses. Radiat Res. 2005;164:17-26. (Pubitemid 40885226)
23. Evans HH, Horng MF, Ricanati M, McCoy EC. Differential antimutagenicity of WR-1065 added after irradiation in L5178Y cell lines. Radiat Res. 1999;151:391-7. (Pubitemid 29268541)
24. Feinendegen LE. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol. 2005;78:3-7. (Pubitemid 40277127)
25. Fujikawa K, Hasegawa Y, Matsuzawa S, Fukunaga A, Itoh T, Kondo S. Dose and dose-rate effects of X rays and fission neutrons on lymphocyte apoptosis in p53(+/+) and p53(-/-) mice. J Radiat Res. 2000;41:113-27.
26. Grassilli E, Desiderio MA, Bellesia E, Salomoni P, Benatti F, Franceschi C. Is polyamine decrease a common feature of apoptosis? Evidence from gamma rays- and heat shock-induced cell death. Biochem Biophys Res Commun. 1995;216:708-14.
27. Grdina DJ, Nagy B, Hill CK, Wells RL, Peraino C. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis. 1985;6:929-31. (Pubitemid 15064158)
28. Grdina DJ, Sigdestad CP, Carnes BA. Protection by WR1065 and WR151326 against fission-neutron-induced mutations at the HGPRT locus in V79 cells. Radiat Res. 1989;117:500-10. (Pubitemid 19100300)
29. Grdina D, Nagy B, Meechan P (1991) Effect of an aminothiol (WR1065) on radiation-induced mutagenesis and cytotoxicity in two repair-deficient mammalian cell lines. Anticarcinogenesis and Radiation Protection, pp. 287-295
30. Grdina DJ, Carnes BA, Grahn D, Sigdestad CP. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1991b;51:4125-30.
31. Grdina DJ, Hunter N, Kataoka Y, Murley JS, Milas L. Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide. Semin Oncol. 1999;26:22-7. (Pubitemid 29246625)
32. Grdina DJ, Kataoka Y, Murley JS. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000;16:237-79. (Pubitemid 32048250)
33. Grdina DJ, Murley JS, Kataoka Y, Epperly W. Relationships between cytoprotection and mutation prevention by WR1065. Mil Med. 2002;167:51-3. (Pubitemid 34174183)
34. Grdina DJ, Murley JS, Kataoka Y, Baker KL, Kunnavakkam R, Coleman MC, et al. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009;73:886-96.
35. Harms-Ringdahl M, Nicotera P, Radford IR. Radiation induced apoptosis. Mutat Res. 1996;366:171-9. (Pubitemid 27008356)
36. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. 1993;7:361-8. (Pubitemid 23067786)
37. Hooker AM, Grdina DJ, Murley JS, Blyth BJ, Ormsby RJ, Bezak E, et al. Low doses of amifostine protect from chromosomal inversions in spleen in vivo when administered after an occupationally relevant X-radiation dose. International Journal of Low Radiation. 2009;6:43-56.
38. Kataoka Y, Perrin J, Hunter N, Milas L, Grdina DJ. Antimutagenic effects of amifostine: clinical implications. Semin Oncol. 1996;23:53-7. (Pubitemid 26321673)
39. Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol. 1996;14:2101-12. (Pubitemid 26230113)
40. Khodarev NN, Kataoka Y, Murley JS, Weichselbaum RR, Grdina DJ. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys. 2004;60:553-63. (Pubitemid 39233477)
41. Koukourakis MI, Ktenidou-Kartali S, Bourikas G, Kartalis G, Tsatalas C. Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients. Cancer Immunol Immunother. 2003;52:127-31. (Pubitemid 36337621)
42. Lawrence MD, Ormsby RJ, Blyth BJ, Bezak E, England G, Newman MR, et al. Lack of high-dose radiation mediated prostate cancer promotion and low-dose radiation adaptive response in the TRAMP mouse model. Radiat Res. 2013;180:376-88.
43. Lee EJ, Gerhold M, Palmer MW, Christen RD. p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection. Br J Cancer. 2003;88:754-9. (Pubitemid 36411456)
44. Liu SC, Murley JS, Woloschak G, Grdina DJ. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. Carcinogenesis. 1997;18:2457-9. (Pubitemid 28134664)
45. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-49. (Pubitemid 23132161)
46. Manola KN, Terzoudi GI, Dardoufas CE, Malik SI, Pantelias GE. Radioprotective effect of amifostine on cells from cancer prone patients and healthy individuals studied by the G2 and PCC assays. Int J Radiat Biol. 2003;79:831-8. (Pubitemid 37468150)
47. Martin K, Potten CS, Kirkwood TB. Age-related changes in irradiation-induced apoptosis and expression of p21 and p53 in crypt stem cells of murine intestine. Ann N Y Acad Sci. 2000;908:315-8. (Pubitemid 30462019)
48. Mazur L, Augustynek A, Deptala A, Halicka HD, Bedner E. Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow. Anticancer Drugs. 2002;13:751-8.
49. Mazur L, Augustynek A, Halicka HD, Deptala A. Induction of apoptosis in bone marrow cells after treatment of mice with WR-2721 and gamma-rays: relationship to the cell cycle. Cell Biol Toxicol. 2003;19:13-27. (Pubitemid 36286343)
50. Mezentsev A, Amundson SA. Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model. Radiat Res. 2011;175:677-88.
51. Milas L, Hunter N, Stephens LC, Peters LJ. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1984;44:5567-9. (Pubitemid 15183558)
52. Mitchell JL, Rupert J, Leyser A, Judd GG. Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065. Biochem J. 1998;335(Pt 2):329-34. (Pubitemid 28491067)
53. Mole RH, Papworth DG, Corp MJ. The dose-response for X-ray induction of myeloid leukaemia in male CBA/H mice. Br J Cancer. 1983;47:285-91. (Pubitemid 13185491)
54. Motoori S, Majima HJ, Ebara M, Kato H, Hirai F, Kakinuma S, et al. Overexpression of mitochondrial manganese superoxide dismutase protects against radiation-induced cell death in the human hepatocellular carcinoma cell line HLE. Cancer Res. 2001;61:5382-8. (Pubitemid 32694915)
55. Murley JS, Kataoka Y, Hallahan DE, Roberts JC, Grdina DJ. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med. 2001;30:1426-39. (Pubitemid 32522958)
56. Murley JS, Kataoka Y, Cao D, Li JJ, Oberley LW, Grdina DJ. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res. 2004;162:536-46. (Pubitemid 39600542)
57. North S, El-Ghissassi F, Pluquet O, Verhaegh G, Hainaut P. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway. Oncogene. 2000;19:1206-14. (Pubitemid 30157551)
58. Paunesku D, Paunesku T, Wahl A, Kataoka Y, Murley J, Grdina DJ, et al. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. Int J Radiat Biol. 2008;84:623-34.
59. Porciani S, Lanini A, Balzi M, Faraoni P, Becciolini A. Polyamines as biochemical indicators of radiation injury. Phys Med. 2001;17 Suppl 1:187-8. (Pubitemid 32823676)
60. Poulin R, Pelletier G, Pegg AE. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem J. 1995;311(Pt 3):723-7.
61. Ribizzi I, Darnowski JW, Goulette FA, Sertoli MR, Calabresi P. Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. Leuk Res. 2000;24:519-25. (Pubitemid 30227231)
62. Riklis E, Kol R, Green M, Prager A, Marko R, Mintsberg M. Increased radioprotection attained by DNA repair enhancement. Pharmacol Ther. 1988;39:311-22.
63. Romano MF, Lamberti A, Bisogni R, Garbi C, Pagnano AM, Auletta P, et al. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. Blood. 1999;94:4060-6.
64. Saavedra MM, Henriquez-Hernandez LA, Lara PC, Pinar B, Rodriguez-Gallego C, Lloret M. Amifostine modulates radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients. J Radiat Res (Tokyo). 2010;51:603-7.
65. Shellabarger CJ, Chmelevsky D, Kellerer AM. Induction of mammary neoplasms in the Sprague-Dawley rat by 430 keV neutrons and X-rays. J Natl Cancer Inst. 1980;64:821-33. (Pubitemid 10134486)
66. Sigdestad CP, Guilford W, Perrin J, Grdina DJ. Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors. Cell Tissue Kinet. 1988;21:193-200. (Pubitemid 19053363)
67. Stamatia P, Marina N, Kareli D, Lialiaris T, Koukourakis MI. Amifostine protects the white cell line against genotoxic damage in patients undergoing pelvic radiotherapy. J Clinic Toxicol. 2012;2:139.
68. Staudacher AH, Blyth BJ, Lawrence MD, Ormsby RJ, Bezak E, Sykes PJ. If bystander effects for apoptosis occur in spleen after low-dose irradiation in vivo then the magnitude of the effect falls within the range of normal homeostatic apoptosis. Radiat Res. 2010;174:727-31.
69. Stefanelli C, Bonavita F, Stanic I, Mignani M, Facchini A, Pignatti C, et al. Spermine causes caspase activation in leukaemia cells. FEBS Lett. 1998;437:233-6. (Pubitemid 28511164)
70. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009;462:1005-10.
71. Tobias KE, Kahana C. Exposure to ornithine results in excessive accumulation of putrescine and apoptotic cell death in ornithine decarboxylase overproducing mouse myeloma cells. Cell Growth Differ. 1995;6:1279-85.
72. Ullrich RL. Tumor induction in BALB/c female mice after fission neutron or gamma irradiation. Radiat Res. 1983;93:506-15. (Pubitemid 13112276)
73. Ullrich RL, Preston RJ. Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or gamma rays. Radiat Res. 1987;109:165-70.
74. Upton AC, Randolph ML, Conklin JW, Kastenbaum MA, Slater M, Melville Jr GS, et al. Late effects of fast neutrons and gamma-rays in mice as influenced by the dose rate of irradiation: induction of neoplasia. Radiat Res. 1970;41:467-91.
75. Warters RL, Roberts JC, Wilmore BH, Kelley LL. Modulation of radiation-induced apoptosis by thiolamines. Int J Radiat Biol. 1997;72:439-48. (Pubitemid 27444519)
76. Woloschak GE, Paunesku T, Chang-Liu CM, Grdina DJ. Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Res. 1995;55:4788-92.
77. Wong GH. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim Biophys Acta. 1995;1271:205-9.
78. Yin E, Nelson DO, Coleman MA, Peterson LE, Wyrobek AJ. Gene expression changes in mouse brain after exposure to low-dose ionizing radiation. Int J Radiat Biol. 2003;79:759-75. (Pubitemid 37468143)
79. Yuhas JM. Protective drugs in cancer therapy: optimal clinical testing and future directions. Int J Radiat Oncol Biol Phys. 1982;8:513-7. (Pubitemid 12090570)
80. Yuhas JM, Storer JB. Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst. 1969;42:331-5.
81. Zech L, Gahrton G, Hammarstrom L, Juliusson G, Mellstedt H, Robert KH, et al. Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia. Nature. 1984;308:858-60. (Pubitemid 14134015)
82. Zois CE, Giatromanolaki A, Sivridis E, Tokmakidis SP, Botaitis S, Simopoulos C, et al. Narrow amifostine dosewindows define radioprotection outcome, following fractionated whole-body irradiation of mice. In Vivo. 2011;25:191-6.